Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04985357
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:06.488470+00:00
Published At
2024-11-25T00:00:00+00:00
Record Updated At
2024-11-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Stage III Breast Cancer", "Stage IV Breast Cancer", "Stage III Lung Cancer", "Stage IV Lung Cancer", "AML", "Multiple Myeloma in Relapse", "Carcinoma", "Carcinoma, Pancreatic", "Carcinoma of Lung", "Carcinoma, Non-Small-Cell Lung", "Carcinoma Breast", "Carcinoma Prostate", "Carcinoma, Hepatocellular", "Carcinoma, Renal Cell", "Carcinoma, Neuroendocrine", "Carcinoma, Small Cell Lung", "Carcinoma, Ovarian", "Carcinoma Bladder", "Carcinoma of Esophagus", "Carcinoma Cervix", "Carcinoma, Thymic", "Carcinoma, Ductal", "Carcinoma of the Head and Neck", "Carcinoma of the Lip", "Carcinoma of the Oral Cavity", "Carcinoma of Unknown Primary", "Carcinoma of the Skin", "Carcinoma of the Anus", "Carcinoma of the Larynx", "Carcinoma of the Penis", "Carcinoma of the Oropharynx", "Carcinoma of the Appendix", "Carcinoma of the Paranasal Sinus", "Carcinoma of the Vulva", "Malignant Pleural Effusion", "Malignant Ascites", "Mesothelioma", "Cholangiocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-11-25"
protocolSection.identificationModule.nctId
"NCT04985357"
protocolSection.identificationModule.officialTitle
"Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs"
protocolSection.statusModule.overallStatus
"WITHDRAWN"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Stage III Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Lung Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Lung Cancer (protocolSection.conditionsModule.conditions)
  • AML (protocolSection.conditionsModule.conditions)
  • Multiple Myeloma in Relapse (protocolSection.conditionsModule.conditions)
  • Carcinoma (protocolSection.conditionsModule.conditions)
  • Carcinoma, Pancreatic (protocolSection.conditionsModule.conditions)
  • Carcinoma of Lung (protocolSection.conditionsModule.conditions)
  • Carcinoma, Non-Small-Cell Lung (protocolSection.conditionsModule.conditions)
  • Carcinoma Breast (protocolSection.conditionsModule.conditions)
  • Carcinoma Prostate (protocolSection.conditionsModule.conditions)
  • Carcinoma, Hepatocellular (protocolSection.conditionsModule.conditions)
  • Carcinoma, Renal Cell (protocolSection.conditionsModule.conditions)
  • Carcinoma, Neuroendocrine (protocolSection.conditionsModule.conditions)
  • Carcinoma, Small Cell Lung (protocolSection.conditionsModule.conditions)
  • Carcinoma, Ovarian (protocolSection.conditionsModule.conditions)
  • Carcinoma Bladder (protocolSection.conditionsModule.conditions)
  • Carcinoma of Esophagus (protocolSection.conditionsModule.conditions)
  • Carcinoma Cervix (protocolSection.conditionsModule.conditions)
  • Carcinoma, Thymic (protocolSection.conditionsModule.conditions)
  • Carcinoma, Ductal (protocolSection.conditionsModule.conditions)
  • Carcinoma of the Head and Neck (protocolSection.conditionsModule.conditions)
  • Carcinoma of the Lip (protocolSection.conditionsModule.conditions)
  • Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)
  • Carcinoma of Unknown Primary (protocolSection.conditionsModule.conditions)
  • Carcinoma of the Skin (protocolSection.conditionsModule.conditions)
  • Carcinoma of the Anus (protocolSection.conditionsModule.conditions)
  • Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
  • Carcinoma of the Penis (protocolSection.conditionsModule.conditions)
  • Carcinoma of the Oropharynx (protocolSection.conditionsModule.conditions)
  • Carcinoma of the Appendix (protocolSection.conditionsModule.conditions)
  • Carcinoma of the Paranasal Sinus (protocolSection.conditionsModule.conditions)
  • Carcinoma of the Vulva (protocolSection.conditionsModule.conditions)
  • Malignant Pleural Effusion (protocolSection.conditionsModule.conditions)
  • Malignant Ascites (protocolSection.conditionsModule.conditions)
  • Mesothelioma (protocolSection.conditionsModule.conditions)
  • Cholangiocarcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.